ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.
… advances drug candidates from early research into clinical testing, ensuring they are thoroughly evaluated for … analysis, and reporting of early- and/or late-phase clinical trials. Deep understanding of CNS disease biology, clinicaltrial methodology, biostatistics, and global regulatory …
Featuring Dr. Byron Lam, Professor, Bascom Palmer Eye Institute, University of Miami School of Medicine
Hosted by Cantor Biotechnology Analysts Emma Nealon, Alethia Young